INS and type 2 diabetes mellitus: The trial was conducted in patients with long-standing T2D who were receiving basal insulin, and, although the majority was receiving insulin glargine therapy at baseline, a diverse range of insulin types was used, reflecting the international nature of the trial sites in this study.